TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12148386

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 1067
Study: 10417865

Group type: EXPERIMENTAL
Intervention: Toborinone infused at 40 micrograms/kg/min for the first 5 min and then at 10 micrograms/kg/min for 85 min (Group A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Toborinone infused at 10 micrograms/kg/min for the entire 90 min (Group B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Comparison between Group A and Group B
Number of subjects: 12
Study: 8644363

Group type: EXPERIMENTAL
Intervention: Double Contrast Barium Enema (DCBE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Colonoscopy
Number of subjects: 44
Study: 1710098

Group type: EXPERIMENTAL
Intervention: Aprotinin (4 x 10(6) KIU) as a continuous infusion and 2 x 10(6) KIU added to pump prime
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 80
Study: 6797734

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erythrityl trinitrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31762390

Group type: EXPERIMENTAL
Intervention: Expressive Deficits
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Asociality
Number of subjects: 147
Study: 30237010

Group type: EXPERIMENTAL
Intervention: rTMS (10 sessions, 10 Hz applied over the left dorsolateral prefrontal cortex)
Number of subjects: 117
Study: 28716146

Group type: EXPERIMENTAL
Intervention: Weekly mobile phone text messaging plus motivational interviewing and usual standard of care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual standard of care
Number of subjects: 60
Study: 25581826

Group type: EXPERIMENTAL
Intervention: Azathioprine alone
Number of subjects: 508

Group type: EXPERIMENTAL
Intervention: Infliximab plus Azathioprine
Number of subjects: 508
Study: 24189760

Group type: EXPERIMENTAL
Intervention: LD-1227
Number of subjects: 60

Group type: COMPARATOR
Intervention: Glucosamine/Chondroitin sulfate
Number of subjects: 60
Study: 21289601

Group type: EXPERIMENTAL
Intervention: yohimbine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: mCPP
Number of subjects: 35

Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 35

Group type: COMPARATOR
Intervention: acamprosate (2997 mg daily)
Number of subjects: 35
Study: 19712767

Group type: EXPERIMENTAL
Intervention: CpG-containing malaria vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no CpG)
Number of subjects: 0
Study: 17200316

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg orally per week for three months)
Number of subjects: 16

Group type: COMPARATOR
Intervention: No therapy (Control Group B)
Number of subjects: 16
Study: 12947133

Group type: EXPERIMENTAL
Intervention: Field conditions
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Standardised conditions
Number of subjects: 32
Study: 11186684

Group type: EXPERIMENTAL
Intervention: Marberger resectoscope
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard resectoscope
Number of subjects: 203
Study: 8610656

Group type: EXPERIMENTAL
Intervention: Vitamin A (200,000 IU oil-soluble)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 1426388

Group type: EXPERIMENTAL
Intervention: Buserelin acetate plus gonadotropins (group B)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Leuprolide acetate plus gonadotropins (group L)
Number of subjects: 35
Study: 3860035

Group type: EXPERIMENTAL
Intervention: HTF medium under oil for fertilization and culture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified Tyrode's medium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Culture in medium under oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Culture in loosely capped tubes
Number of subjects: 0
Study: 3549706

Group type: EXPERIMENTAL
Intervention: External arteriovenous shunts
Number of subjects: 67

Group type: COMPARATOR
Intervention: Modified right atrial catheters
Number of subjects: 67
Study: 30545350

Group type: EXPERIMENTAL
Intervention: Triple therapy (long-acting muscarinic antagonist and long-acting β2-agonist/inhaled corticosteroid)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Dual bronchodilator (ICS withdrawal)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Post-exacerbation (both groups)
Number of subjects: 360
Study: 25795414

Group type: EXPERIMENTAL
Intervention: Low-intensity unsupervised walking exercise intervention for 4 months
Number of subjects: 14
Study: 23818351

Group type: EXPERIMENTAL
Intervention: XELOX chemotherapy (3 cycles)
Number of subjects: 38
Study: 20533638

Group type: EXPERIMENTAL
Intervention: Aluminum oxide‐impregnated polymer points (Enhance Finishing System, Dentsply) followed by diamond‐impregnated micropolishing points (PoGo, Dentsply)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nanotechnology liquid polish system (Lasting Touch, Dentsply)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aluminum oxide‐impregnated polymer points and diamond‐impregnated micropolishing points, then the nanotechnology liquid polish system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 18230972

Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 88
Study: 16699814

Group type: EXPERIMENTAL
Intervention: 1 mg/kg/day Pycnogenol
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 14596629

Group type: EXPERIMENTAL
Intervention: Tiotropium bromide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Ipratropium bromide
Number of subjects: 2
Study: 10957700

Group type: EXPERIMENTAL
Intervention: 800 mg ibuprofen per os and topical placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4 g of a 5% commercial ibuprofen gel topically applied and oral placebo capsules
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Peroral ibuprofen
Number of subjects: 24

Group type: COMPARATOR
Intervention: Commercial ibuprofen gel
Number of subjects: 24
Study: 8771007

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) 4 IU/m2/day subcutaneously for 6 months
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH)
Number of subjects: 11
Study: 1295221

Group type: EXPERIMENTAL
Intervention: Cryoelectrotherapy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Cryo- or cryoelectrotherapy
Number of subjects: 110
Study: 6730991

Group type: EXPERIMENTAL
Intervention: Community treatment provided by the Community Treatment Team, including comprehensive community treatment and a 24-h crisis service.
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard hospital care and after-care (Control group).
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Community treatment (Experimental group).
Number of subjects: 65
Study: 30703216

Group type: EXPERIMENTAL
Intervention: Story sharing intervention (sharing stories in groups) over 3 weeks with 2 to 3 participants sharing five stories.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Baseline sociodemographic characteristics.
Number of subjects: 93
Study: 30044162

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily combined with metformin 500 mg three times daily (Group A)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Simvastatin and metformin individually (Group B)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Simvastatin and metformin individually (Group C)
Number of subjects: 200
Study: 26583379

Group type: EXPERIMENTAL
Intervention: Intrauterine lidocaine
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 24730357

Group type: EXPERIMENTAL
Intervention: 9-week multicomponent intervention
Number of subjects: 494

Group type: COMPARATOR
Intervention: brief workshop control group
Number of subjects: 494
Study: 22383118

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2a (Peg‐IFN‐α2a) ± ribavirin for 24 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2a (Peg‐IFN‐α2a) ± ribavirin for 48 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2a (Peg‐IFN‐α2a) ± ribavirin for 72 weeks
Number of subjects: 114
Study: 20697836

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT) to maintain blood glucose levels from 80 to 110 mg/dl
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional treatment to maintain blood glucose levels less than 151 mg/dl
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy (IIT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 81
Study: 17490958

Group type: EXPERIMENTAL
Intervention: High-AGE meal (HAGE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-AGE meal (LAGE)
Number of subjects: 20
Study: 16197282

Group type: EXPERIMENTAL
Intervention: 4-channel, slow-acting wide dynamic range amplitude compression (WDRC)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Linear amplification
Number of subjects: 2
Study: 11892710

Group type: EXPERIMENTAL
Intervention: Neridronate 200 mg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neridronate 100 mg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neridronate 50 mg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neridronate 25 mg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: All Neridronate doses
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neridronate
Number of subjects: 83
Study: 11113693

Group type: EXPERIMENTAL
Intervention: Dinamap 1846SX (DIN)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Standard mercury sphygmomanometer (SMS)
Number of subjects: 105
Study: 8967094

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion at a dosage of 60 micrograms over 2 hours
Number of subjects: 13

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 13
Study: 1454387

Group type: EXPERIMENTAL
Intervention: Alprazolam (1 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 0
Study: 4048832

Group type: EXPERIMENTAL
Intervention: Secretin infusion (3 CU/kg/h)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Secretin bolus (2 CU/kg)
Number of subjects: 19
Study: 31307814

Group type: EXPERIMENTAL
Intervention: NIRF-guided neck dissection
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conventional neck dissection
Number of subjects: 31
Study: 29726731

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA, 20 min × 5 days)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nondominant-hand 30-Hz VDT
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low-frequency VDT
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nondominant-hand VDT
Number of subjects: 29
Study: 27442225

Group type: EXPERIMENTAL
Intervention: Gain-framed messages with long-term consequences
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loss-framed messages with short-term consequences
Number of subjects: 0
Study: 24020449

Group type: EXPERIMENTAL
Intervention: milTBI (blast-related military TBI)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: civTBI (non-blast civilian TBI)
Number of subjects: 87

Group type: COMPARATOR
Intervention: milCON (military controls)
Number of subjects: 87

Group type: COMPARATOR
Intervention: civCON (civilian controls)
Number of subjects: 87
Study: 22489522

Group type: EXPERIMENTAL
Intervention: Single-segment pedicle screw fixation through the gap of paravertebral muscles
Number of subjects: 65

Group type: COMPARATOR
Intervention: Double-segment pedicle screw fixation through the stripping of paravertebral muscles
Number of subjects: 65
Study: 20692797

Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy (SET) with at least two training sessions per week, each lasting over 30 minutes during the first 3 months.
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: SET with at least 590 minutes of training in the first 3 months.
Number of subjects: 169

Group type: COMPARATOR
Intervention: SET involving only walking vs. a combination of exercises.
Number of subjects: 169

Group type: COMPARATOR
Intervention: Individual vs. group training.
Number of subjects: 169
Study: 18948373

Group type: EXPERIMENTAL
Intervention: Balance plus eye movement exercises (n=10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Balance exercises only (n=9)
Number of subjects: 19
Study: 15906080

Group type: EXPERIMENTAL
Intervention: VO2max(m)(-0.32)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Increase in VO2max from 2.36 l min(-1) to 3.44 l min(-1)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Increase in VO2max from 4.77 l min(-1) to 6.36 l min(-1)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cycling with a side wind
Number of subjects: 79
Study: 12589361

Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus strains (Lactobacillus rhamnosus 19070-2 and Lactobacillus reuteri DSM 122460) given for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10367990

Group type: EXPERIMENTAL
Intervention: Depressed patients (both genders)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Depressed women
Number of subjects: 140

Group type: COMPARATOR
Intervention: Nondepressed volunteers
Number of subjects: 140
Study: 7589684

Group type: EXPERIMENTAL
Intervention: Mast cell blocker (tranilast) 300 mg/d for 3 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2404878

Group type: EXPERIMENTAL
Intervention: 6‐monthly screening by chest X‐ray and sputum cytology
Number of subjects: 6364

Group type: COMPARATOR
Intervention: No asymptomatic investigation (Control)
Number of subjects: 6364
Study: 7364521

Group type: EXPERIMENTAL
Intervention: Traditional trance induction procedure emphasizing relaxation and passivity
Number of subjects: 82

Group type: COMPARATOR
Intervention: No induction (control) treatment
Number of subjects: 82
Study: 30136637

Group type: EXPERIMENTAL
Intervention: Non-collar group (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Collar group (n = 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-collar group (n = 10)
Number of subjects: 23
Study: 28094482

Group type: EXPERIMENTAL
Intervention: Real-time ultrasound guidance for spinal anesthesia
Number of subjects: 38

Group type: COMPARATOR
Intervention: Landmark technique for spinal anesthesia
Number of subjects: 38
Study: 25350973

Group type: EXPERIMENTAL
Intervention: Raltegravir with optimized background therapy (OBT)
Number of subjects: 0
Study: 23497575

Group type: EXPERIMENTAL
Intervention: Complex multifaceted intervention incorporating academic detailing, medicines review with web-based pharmaceutical treatment algorithms, and tailored patient information leaflets.
Number of subjects: 220

Group type: COMPARATOR
Intervention: Usual care with simple patient-level feedback on potentially inappropriate prescribing.
Number of subjects: 220
Study: 22333096

Group type: EXPERIMENTAL
Intervention: Yuangong Cu 365 (YCu365)
Number of subjects: 24000

Group type: EXPERIMENTAL
Intervention: Copper T 380A (TCu380A)
Number of subjects: 24000

Group type: EXPERIMENTAL
Intervention: Multiload Cu 375 (MLCu375)
Number of subjects: 24000

Group type: COMPARATOR
Intervention: YCu365, TCu380A, MLCu375
Number of subjects: 24000
Study: 20449934

Group type: EXPERIMENTAL
Intervention: Oral rapamycin plus bare metal stents (OR + BMS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Drug eluting stents (DES)
Number of subjects: 200
Study: 17276032

Group type: EXPERIMENTAL
Intervention: Peer rejection condition
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Peer success condition
Number of subjects: 115

Group type: COMPARATOR
Intervention: Neutral peer feedback condition
Number of subjects: 115
Study: 14665566

Group type: EXPERIMENTAL
Intervention: Propofol with CPB
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol without CPB (off-pump)
Number of subjects: 40
Study: 11157558

Group type: EXPERIMENTAL
Intervention: Patients with lesions in occipitoparietal and parietotemporal areas
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patients with lesions involving anterior temporal or parietal lobes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patients with lesions involving the human homologue of MT
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patients with MT/V5 lesions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patients with dynamic visual noise
Number of subjects: 50
Study: 9431344

Group type: EXPERIMENTAL
Intervention: Early surgical intervention for acute appendicitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early operation compared with intravenous antibiotics with or without drainage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interval appendectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delay in treatment
Number of subjects: 0
Study: 8172795

Group type: EXPERIMENTAL
Intervention: Adjuvant therapy (timing of quality of life assessment)
Number of subjects: 1389

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 1389
Study: 2597938

Group type: EXPERIMENTAL
Intervention: Imagery instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Muscular activity (pressure applied)
Number of subjects: 0
Study: 189326

Group type: EXPERIMENTAL
Intervention: ACTH/MSH 4‐10
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diluent
Number of subjects: 20
Study: 31691599

Group type: EXPERIMENTAL
Intervention: Passive joint position-matching task with the dominant leg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Passive joint position-matching task with the non-dominant leg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Passive joint position-matching task
Number of subjects: 24
Study: 28183449

Group type: EXPERIMENTAL
Intervention: High meat diet (HMD)
Number of subjects: 49
Study: 25596659

Group type: COMPARATOR
Intervention: Chemoradiotherapy (two cycles of cisplatin 100 mg/m(2) during radiotherapy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus panitumumab (three cycles of panitumumab 9 mg/kg every 3 weeks administered with radiotherapy)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Chemoradiotherapy
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus panitumumab
Number of subjects: 151
Study: 23400966

Group type: EXPERIMENTAL
Intervention: Male circumcision (MC)
Number of subjects: 675

Group type: COMPARATOR
Intervention: Control (uncircumcised men)
Number of subjects: 675
Study: 21546926

Group type: EXPERIMENTAL
Intervention: Cognitive dissonance intervention (N = 21)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Social consensus intervention (N = 22)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control intervention (N = 21)
Number of subjects: 64
Study: 19752406

Group type: EXPERIMENTAL
Intervention: Educational letter indicating stroke symptoms, bookmark, and sticker with emergency medical services' telephone number
Number of subjects: 741

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 741
Study: 17608028

Group type: EXPERIMENTAL
Intervention: FavId, a patient-specific idiotypic vaccine
Number of subjects: 0
Study: 15150204

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate
Number of subjects: 119

Group type: COMPARATOR
Intervention: Sodium chloride
Number of subjects: 119
Study: 11252687

Group type: EXPERIMENTAL
Intervention: Rofecoxib (Vioxx) 12.5 mg qd
Number of subjects: 483

Group type: COMPARATOR
Intervention: Arthrotec (diclofenac 50 mg/misoprostol 200 mcg bid)
Number of subjects: 483
Study: 9891257

Group type: EXPERIMENTAL
Intervention: Rhode Island Stress and Coping Inventory (RISCI)
Number of subjects: 466
Study: 7997000

Group type: EXPERIMENTAL
Intervention: 0.5% malathion lotion
Number of subjects: 193

Group type: COMPARATOR
Intervention: 0.3% d-phenothrin lotion
Number of subjects: 193
Study: 3338252

Group type: EXPERIMENTAL
Intervention: Alveolar carbon monoxide measurement after smoking a cigarette
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Carboxyhaemoglobin measurement after smoking a cigarette
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Alveolar CO measurement taken 5 min after smoking
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Alveolar CO and carboxyhaemoglobin boosts after breathing a 2% CO gas mixture
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Alveolar CO boost measurement after smoking
Number of subjects: 101
Study: 31496353

Group type: EXPERIMENTAL
Intervention: Breathy voice quality in tone identification tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthesized syllables with breathy voice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural stimuli with breathy voice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modal voice quality in tone identification tests
Number of subjects: 0
Study: 29537618

Group type: EXPERIMENTAL
Intervention: Outdoor exercise park for older people
Number of subjects: 0
Study: 28314552

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Attention control class
Number of subjects: 57
Study: 25549314

Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 13
Study: 23034558

Group type: EXPERIMENTAL
Intervention: Home Visiting Nurse (HVN) intervention
Number of subjects: 499

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 499
Study: 20215042

Group type: EXPERIMENTAL
Intervention: Physical activity in individuals with active epilepsy
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Medical comorbidity in individuals with inactive epilepsy
Number of subjects: 125
Study: 18310736

Group type: EXPERIMENTAL
Intervention: Brief relaxation method (BR)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Music distraction (MD)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 90